Zeev Bronfeld

Mr. Bronfeld has served as the Chairman of the Board of Directors since August 2019. He has served on the Board of Directors since December 2006 and as a director of Protalix Ltd. since 1996. Mr. Bronfeld brings vast experience in the management and value building of biotechnology companies. He is an experienced businessman who is involved in a number of biotechnology companies. He was a co-founder of Bio-cell Ltd., a former Israeli publicly-traded holding company that specialized in biotechnology companies, and served as its Chief Executive Officer from 1986 through 2015. Mr. Bronfeld currently serves as a director of Entera Bio Ltd., as well as The Trendlines Group, D.N.A. Biomedical Solutions Ltd., and Electreon Wireless Ltd. (formerly, Biomedix Incubator Ltd.), all of which are public companies. Mr. Bronfeld is also a director of a number of privately-held companies, most of which are involved in the life sciences, such as Contipi Medical Ltd and TransBiodiesel Ltd. From 2008 through January 2017, Mr. Bronfeld served as a director of Macrocure Ltd., a Nasdaq-listed company that merged into Leap Therapeutics, Inc. Mr. Bronfeld received a B.A. in Economics from the Hebrew University in 1975.